X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16000) 16000
Book Review (3862) 3862
Publication (1134) 1134
Book Chapter (204) 204
Book / eBook (163) 163
Conference Proceeding (93) 93
Newsletter (88) 88
Magazine Article (47) 47
Newspaper Article (42) 42
Dissertation (15) 15
Reference (4) 4
Trade Publication Article (3) 3
Data Set (2) 2
Government Document (1) 1
Paper (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (12314) 12314
humans (9394) 9394
male (4585) 4585
animals (4433) 4433
female (4121) 4121
vitamin k - antagonists & inhibitors (2553) 2553
warfarin (2292) 2292
aged (2270) 2270
middle aged (2167) 2167
anticoagulants (1923) 1923
risk factors (1804) 1804
rats (1784) 1784
anticoagulants - therapeutic use (1755) 1755
vitamin d (1656) 1656
adult (1558) 1558
pharmacology & pharmacy (1466) 1466
vitamin k (1412) 1412
anticoagulants - adverse effects (1385) 1385
biochemistry & molecular biology (1352) 1352
atrial fibrillation (1337) 1337
mice (1305) 1305
research (1297) 1297
hematology (1287) 1287
anticoagulants - administration & dosage (1241) 1241
analysis (1169) 1169
administration, oral (1145) 1145
oxidative stress (1118) 1118
vitamins (1110) 1110
peripheral vascular disease (1096) 1096
health aspects (1077) 1077
care and treatment (1011) 1011
prevention (1009) 1009
aged, 80 and over (1006) 1006
stroke (1005) 1005
abridged index medicus (1003) 1003
risk (999) 999
medicine & public health (993) 993
cardiac & cardiovascular systems (969) 969
treatment outcome (898) 898
vitamin-e (855) 855
metabolism (852) 852
dabigatran (851) 851
endocrinology & metabolism (850) 850
therapy (847) 847
physiological aspects (842) 842
medicine, general & internal (834) 834
anticoagulation (809) 809
vitamin k antagonists (809) 809
hemorrhage - chemically induced (801) 801
cancer (793) 793
cell biology (784) 784
international normalized ratio (782) 782
thromboembolism (780) 780
atrial fibrillation - drug therapy (778) 778
dose-response relationship, drug (770) 770
proteins (740) 740
medicine (736) 736
rivaroxaban (731) 731
patients (727) 727
time factors (707) 707
management (699) 699
alfacalcidol (689) 689
oncology (689) 689
calcifediol (684) 684
atrial-fibrillation (658) 658
venous thromboembolism (654) 654
antioxidants (644) 644
vitamin-k antagonists (640) 640
article (637) 637
drug therapy (634) 634
neurosciences (624) 624
vitamin e (616) 616
expression (609) 609
vitamin-d (604) 604
mortality (596) 596
internal medicine (595) 595
research article (595) 595
rodents (589) 589
stroke - prevention & control (589) 589
nutrition & dietetics (586) 586
antioxidants - pharmacology (572) 572
atrial fibrillation - complications (559) 559
vitamin e - pharmacology (557) 557
bleeding (556) 556
studies (556) 556
cells, cultured (551) 551
gene expression (544) 544
apoptosis (541) 541
inflammation (538) 538
review (535) 535
vitamin b (532) 532
diet (529) 529
enzymes (523) 523
thrombosis (523) 523
dietary supplements (522) 522
multidisciplinary sciences (522) 522
pregnancy (511) 511
nutrition (505) 505
medical research (496) 496
warfarin - therapeutic use (491) 491
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (110) 110
UTL at Downsview - May be requested (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
UofT at Mississauga - Stacks (4) 4
Gerstein Science - Reference (3) 3
Chemistry (A D Allen) - Stacks (2) 2
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (2) 2
Online Resources - Online (2) 2
Providence Healthcare - Stacks (2) 2
Scarborough Hospital - General (2) 2
UofT at Scarborough - Stacks (2) 2
Dentistry (Harry R Abbott) - Withdrawn (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Providence Healthcare - Reference (1) 1
Toronto East General Hospital - Stacks (1) 1
Victoria University E.J. Pratt - Storage (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15101) 15101
French (607) 607
German (349) 349
Spanish (113) 113
Russian (94) 94
Japanese (53) 53
Italian (39) 39
Polish (26) 26
Portuguese (26) 26
Danish (24) 24
Hungarian (20) 20
Dutch (14) 14
Korean (12) 12
Chinese (6) 6
Romanian (6) 6
Norwegian (5) 5
Swedish (5) 5
Czech (4) 4
Turkish (3) 3
Bulgarian (2) 2
Croatian (2) 2
Finnish (2) 2
Arabic (1) 1
Slovak (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Circulation, ISSN 0009-7322, 09/2013, Volume 128, Issue 11, pp. 1234 - 1243
BACKGROUND—Patients experiencing major bleeding while taking vitamin K antagonists require rapid vitamin K antagonist reversal. We performed a prospective... 
CARDIAC & CARDIOVASCULAR SYSTEMS | ORAL ANTICOAGULANT REVERSAL | CLINICAL-TRIAL | RECOMBINANT FACTOR-VIII | vitamin K antagonist | prothrombin complex concentrates | PREVIOUSLY UNTREATED PATIENTS | INTRACRANIAL HEMORRHAGE | THERAPY | WARFARIN | TRANSFUSION | HEMOPHILIA-A | anticoagulants | PERIPHERAL VASCULAR DISEASE | plasma | FRESH-FROZEN PLASMA | hemorrhage | Single-Blind Method | Plasma | Prospective Studies | Thromboembolism - chemically induced | Factor IX - therapeutic use | Humans | Middle Aged | Male | Factor IX - adverse effects | Hemorrhage - prevention & control | Vitamin K - antagonists & inhibitors | Thromboembolism - prevention & control | Aged, 80 and over | Adult | Factor X - therapeutic use | Female | Factor X - adverse effects | Factor VII - adverse effects | Factor VII - therapeutic use | Emergencies | Anticoagulants - therapeutic use | Treatment Outcome | Prothrombin - therapeutic use | Anticoagulants - adverse effects | Prothrombin - adverse effects | Hemostatics - adverse effects | International Normalized Ratio | Hemorrhage - drug therapy | Blood Coagulation Factors - adverse effects | Anticoagulants - pharmacology | Blood Coagulation Factors - therapeutic use | Aged | Hemorrhage - chemically induced | Hemostatics - therapeutic use | Drug Combinations | Antidotes - therapeutic use | Antagonists (Biochemistry) | Usage | Care and treatment | Blood coagulation factors | Health aspects | Hemorrhage | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
European Heart Journal, ISSN 0195-668X, 07/2015, Volume 36, Issue 28, pp. 1805 - 1811
Journal Article
Circulation, ISSN 0009-7322, 2015, Volume 132, Issue 13, pp. 1252 - 1260
Background-The safety and effectiveness of non-vitamin K antagonist (VKA) oral anticoagulants, dabigatran or rivaroxaban, were compared with VKA in... 
atrial fibrillation | databases, factual | Databases | Factual | anticoagulants | comparative effectiveness research | France | stroke | hemorrhage | pharmacoepidemiology | CARDIAC & CARDIOVASCULAR SYSTEMS | ANTICOAGULATION CONTROL | METAANALYSIS | QUALITY | EFFICACY | SAFETY | PREVENTION | THERAPY | WARFARIN | ORAL ANTICOAGULANTS | PERIPHERAL VASCULAR DISEASE | Dabigatran - adverse effects | Follow-Up Studies | Humans | Middle Aged | Hospitalization - statistics & numerical data | Warfarin - adverse effects | Risk | Dabigatran - therapeutic use | Thrombophilia - etiology | Warfarin - therapeutic use | Young Adult | Vitamin K - antagonists & inhibitors | Rivaroxaban - adverse effects | Thromboembolism - prevention & control | Adult | Rivaroxaban - therapeutic use | Thrombophilia - drug therapy | Databases, Factual | Antithrombins - therapeutic use | Atrial Fibrillation - complications | Anticoagulants - therapeutic use | Thromboembolism - etiology | Anticoagulants - adverse effects | Arterial Occlusive Diseases - etiology | Factor Xa Inhibitors - therapeutic use | Antithrombins - adverse effects | Factor Xa Inhibitors - adverse effects | Adolescent | Aged | Arterial Occlusive Diseases - prevention & control | Hemorrhage - chemically induced | Antagonists (Biochemistry) | Complications and side effects | Rivaroxaban | Atrial fibrillation | Dosage and administration | Thromboembolism | Drug therapy | Comparative analysis | Hemorrhage | Risk factors | Index Medicus | Abridged Index Medicus | 184 | Original | 185
Journal Article
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 10/2016, Volume 116, Issue 4, pp. 754 - 763
In the RE-LY clinical trial, dabigatran presented a better effectiveness/safety profile when compared to warfarin. However, clinical trials are not very... 
Dabigatran | Vitamin K antagonist | Atrial fibrillation | Real-world | Meta-analysis | POPULATION | SAFETY | RIVAROXABAN | meta-analysis | RISK | MYOCARDIAL ISCHEMIC EVENTS | vitamin K antagonist | INTRACRANIAL HEMORRHAGE | STROKE | real-world | WARFARIN | ORAL ANTICOAGULANTS | dabigatran | PERIPHERAL VASCULAR DISEASE | THROMBOEMBOLISM | HEMATOLOGY
Journal Article
BMJ (Online), ISSN 0959-8146, 2018, Volume 360, pp. j5424 - j5424
Journal Article